The US has picked the DNA centers that will sequence 1 million genomes
A US precision medicine initiative is giving out $28.6 million to three gene sequencing centers to begin decoding the genomes of 1 million American volunteers.
So, what’s it for? The AllofUs study is “one of the country’s most ambitious biomedical research efforts ever undertaken,” according to the National Institutes of Health, which is running the project. It will track the health, diet, and environment of a million people of all races who have handed over their genetic data to the project. So far, more than 110,000 have signed up.
Who: Decoding the DNA of the American volunteers was a coveted job. The winners, announced today, are the Baylor College of Medicine in Texas, the Broad Institute in Cambridge, Massachusetts, and the University of Washington in Seattle.
Only one company, Color Genomics of Burlingame, California, was selected. It will join the Cambridge team and will help provide DNA interpretation and reports—something it does as part of its day-to-day gene testing business.
The sequencing centers picked weren’t exactly outside-the box choices. Some of the same centers led the American part of the Human Genome Project 20 years ago.
Playing catch up: The US gene database will be big … but late to the party. A similar resource in the United Kingdom, the UK Biobank, got under way a decade ago and has been wowing researchers with data on 500,000 mostly middle-aged Britons.
Deep Dive
Biotechnology and health
Scientists are finding signals of long covid in blood. They could lead to new treatments.
Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.
This baby with a head camera helped teach an AI how kids learn language
A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.
The next generation of mRNA vaccines is on its way
Adding a photocopier gene to mRNA vaccines could make them last longer and curb side effects.
Ready, set, grow: These are the biotech plants you can buy now
For $73, I bought genetically modified tomato seeds and a glowing petunia.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.